Wild-type (Agt+/+) and homozygous angiotensinogen deletion mutant (Agt-/-) littermates were placed on normal (NS) or low Na diet (LS) for 2 weeks. Plasma aldosterone levels (P(aldo)) were comparable during NS, and similarly elevated during LS in Agt+/+ and Agt-/-. Moreover, in both, the elevation in P(aldo) was accompanied by marked increase in adrenal zona glomerulosa cells and adrenal P450aldo mRNA. Agt-/- mice were distinguished from Agt+/+ mice by their higher plasma K level, by approximately 1.5 and approximately 3.8 mEq/liter during NS and LS, respectively. Within the Agt-/- group, P(aldo) was directly proportional to plasma K. The importance of K for the hyperaldosteronism during dietary Na restriction was verified by the observation that superimposition of K restriction led to hypotension in Agt+/+ and uniform death in Agt-/- mice along with a reduction in P(aldo) by 75 and 90%, respectively. Thus, suppression of potassium, but not angiotensin, led to a marked attenuation of hyperaldosteronism during dietary Na restriction. Therefore, (a) a powerful angiotensin-independent mechanism exists for the hyperaldosteronism during LS; (b) high K is a central component of this mechanism; (c) contrary to current belief, the tonic effect of high K on aldosterone synthesis and release does not require an intact renin-angiotensin system; and (d) normally, intermediary feedback signals for hyperaldosteronism, i.e., both hypotension and high K, are effectively masked by aldosterone actions.
S Okubo, F Niimura, H Nishimura, F Takemoto, A Fogo, T Matsusaka, I Ichikawa
Title and authors | Publication | Year |
---|---|---|
Impaired aldosterone response to potassium and hyperkalemia in patients receiving a renin-angiotensin-aldosterone system inhibitor
Kim M, Lee HY, Kim H |
The Korean Journal of Internal Medicine | 2025 |
Discontinuing renin-angiotensin system inhibitors after incident hyperkalemia and clinical outcomes: target trial emulation.
Hashimoto N, Sakaguchi Y, Hattori K, Kawano Y, Kawaoka T, Doi Y, Oka T, Kusunoki Y, Yamamoto S, Yamato M, Yamamoto R, Matsui I, Mizui M, Kaimori JY, Isaka Y |
Hypertension research : official journal of the Japanese Society of Hypertension | 2025 |
The renin angiotensin aldosterone system.
Triebel H, Castrop H |
2024 | |
Control of sodium appetite by hindbrain aldosterone-sensitive neurons
Kuralay A, McDonough MC, Resch JM |
Molecular and cellular endocrinology | 2024 |
Aldosterone-induced salt appetite requires HSD2 neurons
Silvia Gasparini, Lila Peltekian, Miriam C. McDonough, Chidera J. A. Mitchell, Marco Hefti, Jon M Resch, Joel C. Geerling |
JCI Insight | 2024 |
Aldosterone-Regulated Sodium Transport and Blood Pressure
Tsilosani A, Gao C, Zhang W |
Frontiers in physiology | 2022 |
Despite increasing aldosterone, elevated potassium is not necessary for activating aldosterone‐sensitive HSD2 neurons or sodium appetite
FS Fazan, E Colombari, AD Loewy, JC Geerling |
Physiological Reports | 2021 |
Signal Transduction of Mineralocorticoid and Angiotensin II Receptors in the Central Control of Sodium Appetite: A Narrative Review
M Iovino, T Messana, G Lisco, A Vanacore, VA Giagulli, E Guastamacchia, GD Pergola, V Triggiani |
International journal of molecular sciences | 2021 |
ENaC in Salt-Sensitive Hypertension: Kidney and Beyond
AL Pitzer, JP Beusecum, TR Kleyman, A Kirabo |
Current Hypertension Reports | 2020 |
Reference Module in Neuroscience and Biobehavioral Psychology
NE Straznicky, EA Lambert, GW Lambert, MD Esler |
Reference Module in Neuroscience and Biobehavioral Psychology | 2017 |
Endocrinology: Adult and Pediatric
M Gurnell, TJ Visser, P Beck-Peccoz, VK Chatterjee |
Endocrinology: Adult and Pediatric | 2016 |
Endocrinology
C Napier, SH Pearce |
Endocrinology | 2016 |
Determinants of water and sodium intake and output
AE Stanhewicz, WL Kenney |
Nutrition Reviews | 2015 |
Mineralocorticoid-Induced Sodium Appetite and Renal Salt Retention: Evidence for Common Signaling and Effector Mechanisms
Y Fu, V Vallon |
Nephron Physiology | 2014 |
Seldin and Giebisch's The Kidney
CJ Cooper, LD Dworkin, WL Henrich |
Seldin and Giebisch's The Kidney | 2013 |
ARB protects podocytes from HIV-1 nephropathy independently of podocyte AT1
A Shimizu, J Zhong, Y Miyazaki, T Hosoya, I Ichikawa, T Matsusaka |
Nephrology Dialysis Transplantation | 2012 |
Acute and Chronic Regulation of Aldosterone Production
NG Hattangady, LO Olala, WB Bollag, WE Rainey |
Molecular and Cellular Endocrinology | 2011 |
Conservation of Na+ vs. K+ by the rat cortical collecting duct
G Frindt, V Houde, LG Palmer |
AJP Renal Physiology | 2011 |
Mineralocorticoid receptor activation and blockade: an emerging paradigm in chronic kidney disease
JP Bertocchio, DG Warnock, F Jaisser |
Kidney International | 2011 |
Mineralocorticoid-receptor Antagonists in Heart Failure: A Tale of Serendipity and Success
A Reyentovich, SD Katz |
Current Heart Failure Reports | 2011 |
Plasma aldosterone levels in patients with coronary artery disease without heart failure or myocardial infarction: implications for pathophsiology, prognosis, and therapy
B Pitt |
European Heart Journal | 2011 |
Mineralocorticoid receptor antagonists for heart failure
AM Richards |
Expert Opinion on Pharmacotherapy | 2011 |
The Role of Mineralocorticoid Receptor Antagonists in Patients with American College of Cardiology/American Heart Association StageB Heart Failure
B Pitt |
Heart Failure Clinics | 2011 |
Conservation of Na + vs. K + by the rat cortical collecting duct
G Frindt, V Houde, LG Palmer |
American journal of physiology. Renal physiology | 2011 |
Minireview: Aldosterone and Mineralocorticoid Receptors: Past, Present, and Future
JW Funder |
Endocrinology | 2010 |
Blocking the RAAS at different levels: an update on the use of the direct renin inhibitors alone and in combination
F Cagnoni, CA Njwe, A Zaninelli, AR Ricci, D Daffra, A D'Ospina, P Preti, M Destro |
Vascular Health and Risk Management | 2010 |
High-salt diet during pregnancy and angiotensin-related cardiac changes
Y Ding, J Lv, C Mao, H Zhang, A Wang, L Zhu, H Zhu, Z Xu |
Journal of Hypertension | 2010 |
Role of the renin-angiotensin-aldosterone system for control of arterial blood pressure following moderate deficit in total body sodium: Balance studies in freely moving dogs
E Seeliger, T Lunenburg, M Ladwig, HW Reinhardt |
Clinical and Experimental Pharmacology and Physiology | 2010 |
Aldosterone: A cardiovascular risk factor?
JW Funder, M Reincke |
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease | 2010 |
Executive Summary: HFSA 2010 Comprehensive Heart Failure Practice Guideline
HF America |
Journal of Cardiac Failure | 2010 |
Aldosterone and Mineralocorticoid Receptors in the Cardiovascular System
JW Funder |
Progress in Cardiovascular Diseases | 2010 |
Aldosterone Antagonists in Heart Failure
M Guglin, O Kristof-Kuteyeva, I Novotorova, P Pratap |
Journal of cardiovascular pharmacology and therapeutics | 2010 |
The Role of Aldosterone Blockade in Patients with Hypertensive Heart and Cardiovascular Disease
B Pitt |
Clinical medicine insights. Therapeutics | 2010 |
Dietary sodium deprivation evokes activation of brain regional neurons and down-regulation of angiotensin II type 1 receptor and angiotensin-convertion enzyme mRNA expression
B Lu, XJ Yang, K Chen, DJ Yang, JQ Yan |
Neuroscience | 2009 |
Long-Term Antiproteinuric Effect of Dual Renin-Angiotensin System Blockade
NR Robles, EF Carbonero, B Romero, ES Casado, JJ Cubero |
Cardiovascular Therapeutics | 2009 |
A novel adipokine CTRP1 stimulates aldosterone production
JH Jeon, K Kim, JH Kim, A Baek, H Cho, YH Lee, JW Kim, D Kim, SH Han, JS Lim, KI Kim, DY Yoon, SH Kim, GT Oh, E Kim, Y Yang |
The FASEB Journal | 2008 |
Aldosterone Breakthrough Caused by Chronic Blockage of Angiotensin II Type 1 Receptors in Human Adrenocortical Cells: Possible Involvement of Bone Morphogenetic Protein-6 Actions
H Otani, F Otsuka, K Inagaki, J Suzuki, T Miyoshi, Y Kano, J Goto, T Ogura, H Makino |
Endocrinology | 2008 |
Effect of Renin-Angiotensin-Aldosterone System Triple Blockade on Non-Diabetic Renal Disease: Addition of an Aldosterone Blocker, Spironolactone, to Combination Treatment with an Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker
Y FURUMATSU, Y NAGASAWA, K TOMIDA, S MIKAMI, T KANEKO, N OKADA, Y TSUBAKIHARA, E IMAI, T SHOJI |
Hypertension Research | 2008 |
Central regulation of sodium appetite: Central regulation of sodium appetite
JC Geerling, AD Loewy |
Experimental Physiology | 2008 |
Aldosterone Blockade in Patients with Chronic Heart Failure
B Pitt |
Cardiology Clinics | 2008 |
The Role of Aldosterone and Mineralocorticoid Receptors in Cardiovascular Disease
JW Funder |
American Journal of Cardiovascular Drugs | 2007 |
Aldosteron und Aldosteronrezeptorantagonisten in der Herzinsuffizienztherapie
T Rau, T Eschenhagen |
Clinical Research in Cardiology Supplements | 2007 |
Drospirenone for Oral Contraception and Hormone Replacement Therapy
A Motivala, B Pitt |
Drugs | 2007 |
Sodium depletion activates the aldosterone-sensitive neurons in the NTS independently of thirst
JC Geerling, AD Loewy |
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology | 2007 |
Drospirenone for Oral Contraception and Hormone Replacement Therapy: Are its Cardiovascular Risks and Benefits the Same as Other Progestogens?
A Motivala, B Pitt |
Drugs | 2007 |
Section 7: Heart Failure in Patients With Left Ventricular Systolic Dysfunction
HF America |
Journal of Cardiac Failure | 2006 |
Executive Summary: HFSA 2006 Comprehensive Heart Failure Practice Guideline
HF America |
Journal of Cardiac Failure | 2006 |
Neurohormones and heart failure: the importance of aldosterone
K Odedra, A Ferro |
International Journal of Clinical Practice | 2006 |
Critical Heart Disease in Infants and Children
BA Fivush, AM Neu, R Parekh, LG Maxwell, LC Racusen, JR White, DG Nichols |
Critical Heart Disease in Infants and Children | 2006 |
Distinct Roles for the Kidney and Systemic Tissues in Blood Pressure Regulation by the Renin-Angiotensin System
Steven D Crowley, Susan B Gurley, Michael I Oliverio, A Kathy Pazmino, Robert Griffiths, Patrick J. Flannery, Robert F. Spurney, Hyung-Suk Kim, Oliver Smithies, Thu H Le & Thomas M Coffman |
Journal of Clinical Investigation | 2005 |
Role of Aldosterone Blockade in Heart Failure
B Pitt |
Heart Failure Clinics | 2005 |
The Role of Aldosterone Blockade in Patients with Heart Failure
B Pitt |
Heart Failure Reviews | 2005 |
Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system
Crowley SD, Gurley SB, Oliverio MI, Pazmino AK, Griffiths R, Flannery PJ, Spurney RF, Kim HS, Smithies O, Le TH, Coffman TM |
Journal of Clinical Investigation | 2005 |
Exploring type I angiotensin (AT1) receptor functions through gene targeting
SD Crowley, PL Tharaux, LP Audoly, TM Coffman |
Acta Physiologica Scandinavica | 2004 |
Angiotensin-converting enzyme inhibitors in the therapy of renal diseases
HP Lefebvre, PL Toutain |
Journal of Veterinary Pharmacology and Therapeutics | 2004 |
The regulation of aldosterone synthase expression
MH Bassett, PC White, WE Rainey |
Molecular and Cellular Endocrinology | 2004 |
Inhibition of RAAS—When is it too much?
P Navarro, R Moskowitz, TH le Jemtel |
Current Heart Failure Reports | 2004 |
Furosemide and the progression of left ventricular dysfunction in experimental heart failure
JM McCurley, SU Hanlon, S Wei, EF Wedam, M Michalski, MC Haigney |
Journal of the American College of Cardiology | 2004 |
Candesartan Prevents Myocardial Fibrosis during Progression of Congestive Heart Failure:
K Onishi, K Dohi, T Koji, K Funabiki, T Kitamura, K Imanaka-Yoshida, M Ito, T Nobori, T Nakano |
Journal of Cardiovascular Pharmacology | 2004 |
Combined angiotensin receptor blocker and ACE inhibitor on myocardial fibrosis and left ventricular stiffness in dogs with heart failure
K Funabiki, K Onishi, K Dohi, T Koji, K Imanaka-Yoshida, M Ito, H Wada, N Isaka, T Nobori, T Nakano |
American journal of physiology. Heart and circulatory physiology | 2004 |
Angiotensin Vol. I
T Unger, BA Schölkens |
2004 | |
Inhibition of RAAS—When is it too much?
P Navarro, R Moskowitz, TH Jemtel |
Current Heart Failure Reports | 2004 |
Diuretic use, progressive heart failure, and death in patients in the studies of left ventricular dysfunction (SOLVD)
M Domanski, J Norman, B Pitt, M Haigney, S Hanlon, E Peyster |
Journal of the American College of Cardiology | 2003 |
Encyclopedia of Hormones
RA DeFronzo, LJ Mandarino |
Encyclopedia of Hormones | 2003 |
The role of mineralocorticoid receptor antagonists in the treatment of cardiac failure
JW Funder |
Expert Opinion on Investigational Drugs | 2003 |
Mineralocorticoid receptor blockade: new insights into the mechanism of action in patients with cardiovascular disease
B Pitt, CT Stier, S Rajagopalan |
Journal of Renin-Angiotensin-Aldosterone System | 2003 |
New biology of aldosterone, and experimental studies on the selective aldosterone blocker eplerenone
JW Funder |
American Heart Journal | 2002 |
Impaired urine concentration and absence of tissue ACE: involvement of medullary transport proteins
JD Klein, DL Quach, JM Cole, K Disher, AK Mongiu, X Wang, KE Bernstein, JM Sands |
American journal of physiology. Renal physiology | 2002 |
Effects of AT 1A receptor deletion on blood pressure and sodium excretion during altered dietary salt intake
AJ Mangrum, RA Gomez, VF Norwood |
American journal of physiology. Renal physiology | 2002 |
Elevated Plasma Aldosterone Levels Despite Complete Inhibition of the Vascular Angiotensin-Converting Enzyme in Chronic Heart Failure
UP Jorde, T Vittorio, SD Katz, PC Colombo, F Latif, TH Jemtel |
Circulation | 2002 |
Aldosterone receptor blockade in the management of heart failure
Emiliano A Palmieri, Bernadette Biondi, Serafino Fazio |
Heart Failure Reviews | 2002 |
Progression and potential regression of glomerulosclerosis
AB Fogo |
Kidney International | 2001 |
Aldosterone in Congestive Heart Failure
KT Weber |
New England Journal of Medicine | 2001 |
ANGIOTENSIN RECEPTOR BLOCKERS AND ALDOSTERONE ANTAGONISTS IN CHRONIC HEART FAILURE
AB Miller, P Srivastava |
Cardiology Clinics | 2001 |
The combination ace-inhibitors plus canreonate in patients with anterior myocardial infarction: safety and tolerability study
PD Pasquale, V Alessi, O Barberi, A Scandurra, V Bucca, G Maringhini, S Scalzo, S Paterna |
International Journal of Cardiology | 2001 |
Review: Gene targeting studies of angiotensin II type 1 (AT1) receptors
TM Coffman, LP Audoly, MI Oliverio |
Journal of Renin-Angiotensin-Aldosterone System | 2001 |
Hyperkalemia, Renal Failure, and Converting-Enzyme Inhibition: An Overrated Connection
NH García, ST Baigorria, LI Juncos |
Hypertension | 2001 |
Eplerenone, a new mineralocorticoid antagonist:in vitro and in vivo studies
JW Funder |
Current Opinion in Endocrinology & Diabetes | 2000 |
Mineralocorticoid receptor knockout mice: Lessons on Na+ metabolism
S Berger, M Bleich, W Schmid, R Greger, G Schütz |
Kidney International | 2000 |
Evolution and Pathophysiology of Chronic Systolic Heart Failure
BE Bleske |
Pharmacotherapy | 2000 |
Insights into the Functions of Type 1 (AT1) Angiotensin II Receptors Provided by Gene Targeting
LP Audoly, MI Oliverio, TM Coffman |
Trends in Endocrinology & Metabolism | 2000 |
An intact renin – angiotensin system is a prerequisite for normal renal development
G Guron, P Friberg |
Journal of Hypertension | 2000 |
Aldosterone and the Heart
M Young, JW Funder |
Trends in Endocrinology & Metabolism | 2000 |
HFSA Guidelines for Management of Patients With Heart Failure Caused by Left Ventricular Systolic Dysfunction—Pharmacological Approaches
KF Adams, KL Baughman, WG Dec, U Elkayam, AD Forker, M Gheorghiade, D Hermann, MA Konstam, P Liu, BM Massie, JH Patterson, MA Silver, LW Stevenson, AM Feldman, JN Cohn, GS Francis, B Greenberg, MA Konstam, C Leier, BH Lorell, M Packer, B Pitt, MA Silver, E Sonnenblick, J Strobeck, R Walsh, S Yusuf |
Pharmacotherapy | 2000 |
The Role of the Renin-Angiotensin-Aldosterone System in the Management of Heart Failure
JE Rodgers, JH Patterson |
Pharmacotherapy | 2000 |
Angiotensin receptors: What is new?
I Ichikawa |
American Journal of Kidney Diseases | 2000 |
Insights derived from ACE knockout mice
J Cole, D Ertoy, KE Bernstein |
Journal of Renin-Angiotensin-Aldosterone System | 2000 |
Captopril Effects on the Rat Adrenal Cortex
D Pignatelli, M Maia, MJ Bento, S Sousa, ME Azevedo, MM Magalhaes, MC Magalhaes, GP Vinson |
Endocrine Research | 2000 |
Renal physiology of the mouse
P Meneton, I Ichikawa, T Inagami, J Schnermann |
American journal of physiology. Renal physiology | 2000 |
Regulation of Sodium Balance and Blood Pressure by the AT 1A Receptor for Angiotensin II
MI Oliverio, CF Best, O Smithies, TM Coffman |
Hypertension | 2000 |
Role of Dietary Potassium in the Hyperaldosteronism and Hypertension of the Remnant Kidney Model
HN Ibrahim, TH Hostetter |
Journal of the American Society of Nephrology : JASN | 2000 |
General overview of mineralocorticoid hormone action
MK Agarwal, M Mirshahi |
Pharmacology & Therapeutics | 1999 |
ROLE OF cAMP IN THE EFFECTS OF K+ ON THE STEROIDOGENESIS OF ZONA GLOMERULOSA CELLS
J Tait, S Tait |
Clinical and Experimental Pharmacology and Physiology | 1999 |
New insights into the renin-angiotensin system and hypertensive renal disease
AB Fogo |
Current Hypertension Reports | 1999 |
Adrenal zonation: clues from 11β-hydroxylase and aldosterone synthase
WE Rainey |
Molecular and Cellular Endocrinology | 1999 |
HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction—pharmacological approaches
HF America |
Journal of Cardiac Failure | 1999 |
Aldosterone and Spironolactone in Heart Failure
KT Weber |
New England Journal of Medicine | 1999 |
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
B Pitt, F Zannad, WJ Remme, R Cody, A Castaigne, A Perez, J Palensky, J Wittes |
New England Journal of Medicine | 1999 |
Mechanism of Cardiac Fibrosis by Angiotensin
T Matsusaka, H Katori, T Homma, I Ichikawa |
Trends in Cardiovascular Medicine | 1999 |
Control of adrenal cell proliferation by AT 1 receptors in response to angiotensin II and low-sodium diet
PE McEwan, GP Vinson, CJ Kenyon |
American journal of physiology. Endocrinology and metabolism | 1999 |
Murine double nullizygotes of the angiotensin type 1A and 1B receptor genes duplicate severe abnormal phenotypes of angiotensinogen nullizygotes
S Tsuchida, T Matsusaka, X Chen, S Okubo, F Niimura, H Nishimura, A Fogo, H Utsunomiya, T Inagami, I Ichikawa |
Journal of Clinical Investigation | 1998 |
Hypertension
P Hamet, Z Pausova, V Adarichev, K Adaricheva, J Tremblay |
Journal of Hypertension | 1998 |
Endocrinological abnormalities in angiotensinogen-gene knockout mice
S Umemura, M Kihara, Y Sumida, M Yabana, T Ishigami, K Tamura, N Nyui, K Hibi, K Murakami, A Fukamizu, M Ishii |
Journal of Hypertension | 1998 |
Genetic deficiency of angiotensinogen produces an impaired urine concentrating ability in mice
M Kihara, S Umemura, Y Sumida, N Yokoyama, M Yabana, N Nyui, K Tamura, K Murakami, A Fukamizu, M Ishii |
Kidney International | 1998 |
Endocrinology of Cardiovascular Function
ER Levin, JL Nadler |
1998 | |
Primary Aldosteronism
AJ Hellem |
Acta Medica Scandinavica | 1956 |